nexplanon 68 mg implantat
paranova danmark a/s - etonogestrel - implantat - 68 mg
nexplanon 68 mg implantat
n.v. organon - etonogestrel - implantat - 68 mg
enrylaze
jazz pharmaceuticals ireland limited - crisantaspase - forløbercellelimfoblastisk leukæmi-lymfom - antineoplastiske midler - enrylaze is indicated as a component of a multi-agent chemotherapeutic regimen for the treatment of acute lymphoblastic leukaemia (all) and lymphoblastic lymphoma (lbl) in adult and paediatric patients (1 month and older) who developed hypersensitivity or silent inactivation to e. coli-derived asparaginase.
iluvien 190 mikrogram intravitreal implantat i applikator
alimera sciences europe ltd. - fluocinolonacetonid - intravitreal implantat i applikator - 190 mikrogram
tepadina
adienne s.r.l. s.u. - thiotepa - hematopoietisk stamcelletransplantation - antineoplastiske midler - i kombination med andre kemoterapeutiske lægemidler:med eller uden total body bestråling (tbi) som konditionering behandling forud for allogen eller autolog hæmatopoietisk stamcelletransplantation (hpct) hæmatologiske sygdomme hos voksne og pædiatriske patienter, når høj-dosis kemoterapi med hpct support er passende til behandling af solide tumorer hos voksne og pædiatriske patienter. det foreslås, at tepadina skal ordineres af læger med erfaring i plejende behandling forud for hæmatopoietisk stamcelletransplantation.
leuprorelin "sandoz" 3,6 mg implantat, fyldt injektionssprøjte
sandoz a/s - leuprorelinacetat - implantat, fyldt injektionssprøjte - 3,6 mg
leuprorelin "sandoz" 5 mg implantat, fyldt injektionssprøjte
sandoz a/s - leuprorelinacetat - implantat, fyldt injektionssprøjte - 5 mg
thiotepa riemser
esteve pharmaceuticals gmbh - thiotepa - hematopoietic stem cell transplantation; neoplasms - antineoplastiske midler - thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients. thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients.
gentacoll 1,3 mg/cm2 implantat
serb s.a. - gentamicinsulfat - implantat - 1,3 mg/cm2
gentamicin "2care4" 1,3 mg/cm2 implantat
2care4 aps - gentamicinsulfat - implantat - 1,3 mg/cm2